Immunogenicity Prediction and Mitigation

Immunogenicity of therapeutic proteins can render the product ineffective and potentially dangerous. Investigators need to know what causes immunogenicity and how to identify immunogenic features to enable them to design their product accordingly. This track will showcase cutting-edge approaches for the identification of risk factors and for designing non-immunogenic biotherapeutics.